<DOC>
	<DOC>NCT02837445</DOC>
	<brief_summary>The purpose of this double blind randomized study is the evaluation of the safety and efficacy of the Moderato System. The Moderato pacemaker is indicated for patients who require a dual chamber pacemaker and also have hypertension, in order to reduce their blood pressure.</brief_summary>
	<brief_title>Moderato System: A Double-Blind Randomized Trial</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<mesh_term>Atrioventricular Block</mesh_term>
	<mesh_term>Coronary Vasospasm</mesh_term>
	<criteria>Requirement of dual chamber pacemaker. Stable (at least 1 month) hypertension treatment with at least 1 antihypertensive drug, which is anticipated to be maintained for at least 7 months. Average day time (7AM10PM) ambulatory systolic blood pressure ≥ 130 mmHg and office blood pressure ≥140 mmHg. Subject lives in the proximity of the study center, which will permit compliance with study visits for at least 7 months. Known secondary cause of HTN. Average ambulatory or office systolic BP &gt; 195 mmHg. Permanent atrial fibrillation. History of significant paroxysmal atrial fibrillation/flutter burden (defined as &gt;25% of beats). Cardiac ejection fraction &lt;50%. Symptoms of heart failure, NYHA Class II or greater. Hypertrophic cardiomyopathy, restrictive cardiomyopathy or interventricular septal thickness ≥ 15 mm. Subject is on dialysis. Subject has an estimated Glomerular Filtration Rate &lt; 30 ml/min/1.73 m² Prior neurological events (stroke or TIA) within the past year or events at a prior time that has resulted in residual neurologic deficit. Carotid artery disease. Known autonomic dysfunction. History of clinically significant uncontrolled ventricular tachyarrhythmia or has experienced sudden death. Previous active devicebased treatment for HTN. Existing implant, other than a pacemaker that needs replacing. Subject is or has the possibility of becoming pregnant and is unwilling of contraception during the study. Subject is unwilling or cannot provide Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>